Talzenna Capsule, Liquid Filled
Product Images NDC 63539-025

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 63539-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Talzenna 01)

Chemical structure diagram showing the molecular structure of talazoparib, the active ingredient in Talzenna. The diagram includes detailed rings and functional groups consistent with talazoparib's chemical composition.*

FDA Label Image

Figure 1 (Talzenna 02)

A Kaplan-Meier curve showing progression-free survival probability over time in months, comparing Talzenna versus chemotherapy. The graph plots percentage survival on the vertical axis and months on the horizontal axis, with Talzenna represented by a solid line and chemotherapy by a dashed line. Tabulated patient numbers at risk are presented below the graph for both treatment groups.*

FDA Label Image

Figure 2 (Talzenna 03)

A Kaplan-Meier curve chart depicting overall survival probability (%) over time in months, comparing Talzenna (talazoparib) treatment with chemotherapy. The chart shows the number of patients at risk for each treatment group at different time points from 0 to 60 months.*

FDA Label Image

Figure 3 (Talzenna 03a)

A Kaplan-Meier survival curve graph showing progression-free survival probability (%) over time in months. It compares TALZENNA + Enzalutamide (solid line) with Placebo + Enzalutamide (dashed line), including number of patients at risk for each treatment group at various time points up to 42 months.*

FDA Label Image

Logo (Talzenna 04)

FDA Label Image

Logo (Talzenna 04a)

FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Label)

Label for Talzenna 0.5 mg capsules, a liquid-filled oral capsule containing talazoparib. The label shows the brand name Talzenna and generic name talazoparib, with a green bar indicating the 0.5 mg strength. The package contains 30 capsules and is labeled Rx only. The label states distribution by U.S. Pharmaceuticals and Pfizer Inc., New York, NY, and that the product is made in Germany.*

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Label)

Talzenna 1 mg capsules label by Pfizer, showing talazoparib as the active ingredient. The label specifies 30 capsules per package, with storage instructions and mentions distribution by U.S. Pharmaceuticals. It includes the text 'Professional Sample-Not For Sale' and 'Rx only.' The capsules are liquid-filled and intended for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.